Test Summary Sheet for:

Purpose
Exposure Monitoring/Abuse Monitoring. Over the last six years, NMS Labs has continually invested in research and intelligence gathering, then rapid test development and thorough validation to ensure we are offering testing for the most current synthetic cannabinoids in the rapidly changing designer drug/NPS arena. This test is designed to meet the needs of clinicians and researchers by identifying exposure to synthetic cannabinoids using serum or plasma samples. This is a directed analysis.  If you require a forensically defensible test which includes a screen and confirmation of positive analytes, please contact NMS Labs
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80352x2
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 5-fluoro-MMB-PINACA 5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.05 Synthetic Cannabinoid
2 CUMYL-THPINACA N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
3 MDMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
4 MMB-FUBINACA FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
5 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
6 MMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
7 MDMB-FUBINACA / EMB-FUBINACA 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
8 5-fluoro-EDMB-PINACA ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
9 NA-FUBIM (1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
10 5-fluoro-QU-PINAC 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
11 MMB-CHMICA methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
12 NA-FUBIC 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
13 MDMB-CHMICA methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
14 5-fluoro-NA-PIC naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
15 MMB-CHMINACA MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
16 MDMB-CHMINAC MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
17 ADAMANTYL-FUBINACA FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
18 MDMB-CHMCZCA methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
19 AMB-FUBINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
20 ADMB-FUBINACA ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
21 ADMB-FUBICA ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
22 4-cyano-CUMYL-BINACA 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
23 AMB-CHMINACA AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
24 5-fluoro-MDMB-PICA methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
25 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid

Test Also Known As
5-fluoro-AMP; K2; Spice; Synthetic Cannabinoid
Specimen Type
Serum or Plasma
Requested Volume
3 mL
Minimum Volume
1.4 mL
Special Handling
Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Received Room Temperature. Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 2 day(s)
Refrigerated: 14 day(s)
Frozen (-20 °C): 14 day(s)
1 5-fluoro-MMB-PINACA 5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.05 Synthetic Cannabinoid
2 CUMYL-THPINACA N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
3 MDMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
4 MMB-FUBINACA FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
5 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
6 MMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
7 MDMB-FUBINACA / EMB-FUBINACA 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
8 5-fluoro-EDMB-PINACA ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
9 NA-FUBIM (1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
10 5-fluoro-QU-PINAC 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
11 MMB-CHMICA methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
12 NA-FUBIC 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
13 MDMB-CHMICA methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
14 5-fluoro-NA-PIC naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
15 MMB-CHMINACA MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
16 MDMB-CHMINAC MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
17 ADAMANTYL-FUBINACA FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
18 MDMB-CHMCZCA methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
19 AMB-FUBINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
20 ADMB-FUBINACA ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
21 ADMB-FUBICA ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
22 4-cyano-CUMYL-BINACA 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
23 AMB-CHMINACA AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Synthetic Cannabinoid
24 5-fluoro-MDMB-PICA methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
25 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.